Human serum albumin-based nanoparticles alter raloxifene administration and improve bioavailability

Osteoporosis is a disease that reduces bone mass and microarchitecture, which makes bones fragile. Postmenopausal osteoporosis occurs due to estrogen deficiency. Raloxifene is a selective estrogen receptor modulator used to treat postmenopausal osteoporosis. However, it has a low bioavailability, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shu-Jyuan, Chang, Chih-Hao, Young, Tai-Horng, Wang, Chung-Hao, Tseng, Tzu-Hao, Wang, Man-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387319/
https://www.ncbi.nlm.nih.gov/pubmed/35975329
http://dx.doi.org/10.1080/10717544.2022.2111479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387319/
https://www.ncbi.nlm.nih.gov/pubmed/35975329
http://dx.doi.org/10.1080/10717544.2022.2111479

Ejemplares similares